Ailar Nakhlband, Jaleh Barar*
|
Original Research
COVID-19
Khalil Ansarin , Ramin Tolouian, Mohammadreza Ardalan* , Ali Taghizadieh, Mojtaba Varshochi, Soheil Teimouri, Tahere Vaezi, Hamed Valizadeh, Parviz Saleh, Saeid Safiri , Kenneth R. Chapman
Based on a randomized clinical trial, bromhexine is proposed as a potential therapeutic option in COVID-19. A total of 78 patients with similar demographic and disease characteristics were treated with results showing a significant reduction in ICU admissions.
|
Bryson C. Lochte, Sean A Guillory, Craig A. H. Richard*, William M. Kelley
|
|
Navid Hosseini Mansoub*, Mehmet Gürdal, Elif Karadadaş, Hilal Kabadayi, Seda Vatansever, Gulinnaz Ercan
|
Morteza Mahmoudi, Mingming Zhao, Yuka Matsuura, Sophie Laurent, Phillip C. Yang, Daniel Bernstein, Pilar Ruiz-Lozano*, Vahid Serpooshan*
|
Yalda RahbarSaadat, Nazli Saeidi, Sepideh Zununi Vahed, Abolfazl Barzegari*, Jaleh Barar
|
Ali Nokhodchi*, Shaista Raja, Pryia Patel, Kofi Asare-Addo
|
Farhad Shokraneh* , Clive Elliott Adams
|
Jaleh Barar , Ayuob Aghanejad, Marziyeh Fathi, Yadollah Omidi*
|